Regulation of pulmonary inflammation by mesenchymal cells

Pulmonary Pharmacology and Therapeutics

Volumn 29, Issue 2, 2014, Pages 156e165-165

  Alkhouri, Hatem ^a   Poppinga, Wilfred Jelco ^b,c   Tania, Navessa Padma ^b,c   Ammit, Alaina ^a   Schuliga, Michael ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cell adhesion molecule (CAM); Chemokine; Cytokine; Extracellular matrix (ECM); Macrophage; Mast cell

Indexed keywords

CD59 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CYCLIC AMP; CYTOKINE; ENZYME PRECURSOR; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GROWTH FACTOR; HEAT SHOCK PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPOCORTIN 1; LIPOCORTIN 2; LIPOCORTIN 4; LIPOXIN; OMEGA 3 FATTY ACID; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; RANTES; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR 3; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE;

ARTICLE; ASTHMA; BLOOD CLOTTING; CELL INTERACTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; CYTOKINE RELEASE; DISEASE COURSE; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS CELL; LUNG FIBROBLAST; MACROPHAGE; MAST CELL; MESENCHYME CELL; MONOCYTE; NONHUMAN; PLASMINOGEN ACTIVATION; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY MESENCHYMAL CELL; SMOOTH MUSCLE FIBER; AIRWAY REMODELING; ANIMAL; LUNG DISEASES; MESENCHYMAL STROMA CELL; PATHOPHYSIOLOGY; PHYSIOLOGY;

AIRWAY REMODELING; ANIMALS; HUMANS; LUNG DISEASES; MESENCHYMAL STROMAL CELLS; PNEUMONIA;

EID: 84922642066     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2014.03.001     Document Type: Article

References (177)

1. WHO Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach 2007, 155. J. Bousquet, N.G. Khaltaev (Eds.).
2. Decramer M., Janssens W., Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012, 379(9823):1341-1351. Epub 2012/02/09.
3. Ding Q., Luckhardt T., Hecker L., Zhou Y., Liu G., Antony V.B., et al. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis. Drugs 2011, 71(8):981-1001. Epub 2011/06/15.
4. Shlobin O.A., Nathan S.D. Pulmonary hypertension secondary to interstitial lung disease. Expert Rev Respir Med 2011, 5(2):179-189. Epub 2011/04/23.
5. Durham A., Adcock I.M., Tliba O. Steroid resistance in severe asthma: current mechanisms and future treatment. Curr Pharm Des 2011, 17(7):674-684. Epub 2011/03/17.
6. Tetley T.D. Inflammatory cells and chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy 2005, 4(6):607-618. Epub 2007/02/20.
7. Tubby C., Harrison T., Todd I., Fairclough L. Immunological basis of reversible and fixed airways disease. Clin Sci (Lond) 2011, 121(7):285-296. Epub 2011/06/10.
8. Papiris S.A., Kollintza A., Karatza M., Manali E.D., Sotiropoulou C., Milic-Emili J., et al. CD8+ T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis. JInflamm (Lond) 2007, 4:14. Epub 2007/06/21.
9. Savai R., Pullamsetti S.S., Kolbe J., Bieniek E., Voswinckel R., Fink L., et al. Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2012, 186(9):897-908. Epub 2012/09/08.
10. Amin K., Ludviksdottir D., Janson C., Nettelbladt O., Bjornsson E., Roomans G.M., et al. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med 2000, 162(6):2295-2301. Epub 2000/12/09.
11. Gosselink J.V., Hayashi S., Elliott W.M., Xing L., Chan B., Yang L., et al. Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 181(12):1329-1335. Epub 2010/01/16.
12. Noble P.W., Barkauskas C.E., Jiang D. Pulmonary fibrosis: patterns and perpetrators. JClin Invest 2012, 122(8):2756-2762. Epub 2012/08/02.
13. Hopkins N., McLoughlin P. The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?. JAnat 2002, 201(4):335-348. Epub 2002/11/15.
14. Fixman E.D., Stewart A., Martin J.G. Basic mechanisms of development of airway structural changes in asthma. Eur Respir J 2007, 29(2):379-389.
15. Redington A.E. Airway fibrosis in asthma: mechanisms, consequences, and potential for therapeutic intervention. Monaldi Arch Chest Dis 2000, 55(4):317-323. Epub 2000/11/01.
16. Koziol-White C.J., Panettieri R.A. Airway smooth muscle and immunomodulation in acute exacerbations of airway disease. Immunol Rev 2011, 242(1):178-185. Epub 2011/06/21.
17. Ward J.E., Harris T., Bamford T., Mast A., Pain M.C., Robertson C., et al. Proliferation is not increased in airway myofibroblasts isolated from asthmatics. Eur Respir J 2008, 32(2):362-371.
18. Flavell S.J., Hou T.Z., Lax S., Filer A.D., Salmon M., Buckley C.D. Fibroblasts as novel therapeutic targets in chronic inflammation. Br J Pharmacol 2008, 153(Suppl.1):S241-S246. Epub 2007/10/30.
19. Li M., Riddle S.R., Frid M.G., El Kasmi K.C., McKinsey T.A., Sokol R.J., et al. Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension. JImmunol 2011, 187(5):2711-2722. Epub 2011/08/05.
20. Xia Y.C., Redhu N.S., Moir L.M., Koziol-White C., Ammit A.J., Al-Alwan L., et al. Pro-inflammatory and immunomodulatory functions of airway smooth muscle: emerging concepts. Pulm Pharmacol Ther 2013, 26(1):64-74. Epub 2012/05/29.
21. Evanko S.P., Potter-Perigo S., Bollyky P.L., Nepom G.T., Wight T.N. Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Matrix Biol 2012, 31(2):90-100. Epub 2011/12/14.
22. Li Y., Jiang D., Liang J., Meltzer E.B., Gray A., Miura R., et al. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. JExp Med 2011, 208(7):1459-1471. Epub 2011/06/29.
23. Alkhouri H., Moir L.M., Armour C.L., Hughes J.M. CXCL1 is a negative regulator of mast cell chemotaxis to airway smooth muscle cell products invitro. Clin Exp Allergy 2014, 44(3):381-392.
24. Jia Y., Morand E.F., Song W., Cheng Q., Stewart A., Yang Y.H. Regulation of lung fibroblast activation by annexin A1. JCell Physiol 2013, 228(2):476-484. Epub 2012/07/11.
25. Elias J.A., Wu Y., Zheng T., Panettieri R. Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am J Physiol 1997, 273(3 Pt 1):L648-L655. Epub 1997/10/08.
26. Rudd B.D., Burstein E., Duckett C.S., Li X., Lukacs N.W. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. JVirol 2005, 79(6):3350-3357. Epub 2005/02/26.
27. Saunders M.A., Mitchell J.A., Seldon P.M., Yacoub M.H., Barnes P.J., Giembycz M.A., et al. Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone. Br J Pharmacol 1997, 120(4):545-546.
28. Fitzgerald S.M., Chi D.S., Hall H.K., Reynolds S.A., Aramide O., Lee S.A., et al. GM-CSF induction in human lung fibroblasts by IL-1beta, TNF-alpha, and macrophage contact. JInterferon Cytokine Res 2003, 23(2):57-65. Epub 2003/05/15.
29. Knight D.A., Lydell C.P., Zhou D., Weir T.D., Robert Schellenberg R., Bai T.R. Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release. Am J Respir Cell Mol Biol 1999, 20(4):834-841. Epub 1999/04/01.
30. Burgess J.K., Carlin S., Pack R.A., Arndt G.M., Au W.W., Johnson P.R., et al. Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma?. JAllergy Clin Immunol 2004, 113(4):683-689. Epub 2004/04/22.
31. Issa R., Xie S., Khorasani N., Sukkar M., Adcock I.M., Lee K.Y., et al. Corticosteroid inhibition of growth-related oncogene protein-alpha via mitogen-activated kinase phosphatase-1 in airway smooth muscle cells. JImmunol 2007, 178(11):7366-7375. Epub 2007/05/22.
32. Brant K.A., Fabisiak J.P. Nickel and the microbial toxin, MALP-2, stimulate proangiogenic mediators from human lung fibroblasts via a HIF-1alpha and COX-2-mediated pathway. Toxicol Sci 2009, 107(1):227-237. Epub 2008/10/04.
33. Pang L., Knox A.J. Bradykinin stimulates IL-8 production in cultured human airway smooth muscle cells: role of cyclooxygenase products. JImmunol 1998, 161(5):2509-2515. Epub 1998/09/02.
34. Brightling C.E., Ammit A.J., Kaur D., Black J.L., Wardlaw A.J., Hughes J.M., et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 2005, 171(10):1103-1108.
35. Hardaker E.L., Bacon A.M., Carlson K., Roshak A.K., Foley J.J., Schmidt D.B., et al. Regulation of TNF-alpha- and IFN-gamma-induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary disease. FASEB J 2004, 18(1):191-193. Epub 2003/11/05.
36. Dong S., Zhang X., He Y., Xu F., Li D., Xu W., et al. Synergy of IL-27 and TNF-alpha in regulating CXCL10 expression in lung fibroblasts. Am J Respir Cell Mol Biol 2013, 48(4):518-530. Epub 2013/01/22.
37. Wuyts W.A., Vanaudenaerde B.M., Dupont L.J., Demedts M.G., Verleden G.M. Modulation by cAMP of IL-1beta-induced eotaxin and MCP-1 expression and release in human airway smooth muscle cells. Eur Respir J 2003, 22(2):220-226. Epub 2003/09/04.
38. Holgate S.T., Bodey K.S., Janezic A., Frew A.J., Kaplan A.P., Teran L.M. Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 1997, 156(5):1377-1383. Epub 1997/12/31.
39. John M., Hirst S.J., Jose P.J., Robichaud A., Berkman N., Witt C., et al. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. JImmunol 1997, 158(4):1841-1847. Epub 1997/02/15.
40. Choi E.S., Jakubzick C., Carpenter K.J., Kunkel S.L., Evanoff H., Martinez F.J., et al. Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia. Am J Respir Crit Care Med 2004, 170(5):508-515. Epub 2004/06/12.
41. Ghaffar O., Hamid Q., Renzi P.M., Allakhverdi Z., Molet S., Hogg J.C., et al. Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells. Am J Respir Crit Care Med 1999, 159(6):1933-1942. Epub 1999/06/03.
42. Fritz D.K., Kerr C., Botelho F., Stampfli M., Richards C.D., Oncostatin M. (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1. Exp Cell Res 2009, 315(20):3486-3499. Epub 2009/10/06.
43. Faffe D.S., Whitehead T., Moore P.E., Baraldo S., Flynt L., Bourgeois K., et al. IL-13 and IL-4 promote TARC release in human airway smooth muscle cells: role of IL-4 receptor genotype. Am J Physiol Lung Cell Mol Physiol 2003, 285(4):L907-L914. Epub 2003/07/23.
44. Kaur D., Saunders R., Berger P., Siddiqui S., Woodman L., Wardlaw A., et al. Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. Am J Respir Crit Care Med 2006, 174(11):1179-1188. Epub 2006/09/09.
45. Jarai G., Sukkar M., Garrett S., Duroudier N., Westwick J., Adcock I., et al. Effects of interleukin-1beta, interleukin-13 and transforming growth factor-beta on gene expression in human airway smooth muscle using gene microarrays. Eur J Pharmacol 2004, 497(3):255-265. Epub 2004/09/01.
46. Sukkar M.B., Issa R., Xie S., Oltmanns U., Newton R., Chung K.F. Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-gamma and TNF-alpha and regulation by TGF-beta and corticosteroids. Am J Physiol Lung Cell Mol Physiol 2004, 287(6):L1230-L1240. Epub 2004/08/24.
47. Kassel O., Schmidlin F., Duvernelle C., Gasser B., Massard G., Frossard N. Human bronchial smooth muscle cells in culture produce stem cell factor. Eur Respir J 1999, 13(5):951-954. Epub 1999/07/22.
48. Panettieri R.A., Lazaar A.L., Pure E., Albelda S.M. Activation of cAMP-dependent pathways in human airway smooth muscle cells inhibits TNF-alpha-induced ICAM-1 and VCAM-1 expression and T lymphocyte adhesion. JImmunol 1995, 154(5):2358-2365. Epub 1995/03/01.
49. Spoelstra F.M., Postma D.S., Hovenga H., Noordhoek J.A., Kauffman H.F. Interferon-gamma and interleukin-4 differentially regulate ICAM-1 and VCAM-1 expression on human lung fibroblasts. Eur Respir J 1999, 14(4):759-766. Epub 1999/11/26.
50. Burgess J.K., Blake A.E., Boustany S., Johnson P.R., Armour C.L., Black J.L., et al. CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. JAllergy Clin Immunol 2005, 115(2):302-308. Epub 2005/02/08.
51. Lazaar A.L., Albelda S.M., Pilewski J.M., Brennan B., Pure E., Panettieri R.A. Tlymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. JExp Med 1994, 180(3):807-816. Epub 1994/09/01.
52. Pechkovsky D.V., Prele C.M., Wong J., Hogaboam C.M., McAnulty R.J., Laurent G.J., et al. STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF. Am J Pathol 2012, 180(4):1398-1412. Epub 2012/02/11.
53. Weylandt K.H., Chiu C.Y., Gomolka B., Waechter S.F., Wiedenmann B. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat 2012, 97(3-4):73-82. Epub 2012/02/14.
54. Aoki H., Hisada T., Ishizuka T., Utsugi M., Ono A., Koga Y., et al. Protective effect of resolvin E1 on the development of asthmatic airway inflammation. Biochem Biophys Res Commun 2010, 400(1):128-133. Epub 2010/08/17.
55. Levy B.D., Kohli P., Gotlinger K., Haworth O., Hong S., Kazani S., et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. JImmunol 2007, 178(1):496-502. Epub 2006/12/22.
56. Wang B., Gong X., Wan J.Y., Zhang L., Zhang Z., Li H.Z., et al. Resolvin D1 protects mice from LPS-induced acute lung injury. Pulm Pharmacol Ther 2011, 24(4):434-441. Epub 2011/04/20.
57. Rogerio A.P., Haworth O., Croze R., Oh S.F., Uddin M., Carlo T., et al. Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. JImmunol 2012, 189(4):1983-1991. Epub 2012/07/18.
58. Miyata J., Fukunaga K., Iwamoto R., Isobe Y., Niimi K., Takamiya R., et al. Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. JAllergy Clin Immunol 2013, 131(2):353-360. .e1-2. Epub 2012/09/26.
59. Levy B.D. Resolvin D1 and resolvin E1 promote the resolution of allergic airway inflammation via shared and distinct molecular counter-regulatory pathways. Front Immunol 2012, 3:390. Epub 2013/01/08.
60. Hsiao H.M., Sapinoro R.E., Thatcher T.H., Croasdell A., Levy E.P., Fulton R.A., et al. Anovel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation. PLoS One 2013, 8(3):e58258. Epub 2013/03/14.
61. Wu D., Zheng S., Li W., Yang L., Liu Y., Zheng X., et al. Novel biphasic role of resolvin D1 on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts is partly through PI3K/AKT and ERK2 pathways. Mediators Inflamm 2013, 2013:964012. Epub 2013/11/01.
62. Millien V.O., Lu W., Shaw J., Yuan X., Mak G., Roberts L., et al. Cleavage of fibrinogen by proteinases elicits allergic responses through Toll-like receptor 4. Science 2013, 341(6147):792-796. Epub 2013/08/21.
63. Stewart A.G., Xia Y.C., Harris T., Royce S., Hamilton J.A., Schuliga M. Plasminogen-stimulated airway smooth muscle cell proliferation is mediated by urokinase and annexin A2, involving plasmin-activated cell signalling. Br J Pharmacol 2013, 170(7):1421-1435. Epub 2013/10/12.
64. Brant K.A., Fabisiak J.P. Nickel alterations of TLR2-dependent chemokine profiles in lung fibroblasts are mediated by COX-2. Am J Respir Cell Mol Biol 2008, 38(5):591-599. Epub 2007/12/22.
65. Sugiura H., Ichikawa T., Koarai A., Yanagisawa S., Minakata Y., Matsunaga K., et al. Activation of Toll-like receptor 3 augments myofibroblast differentiation. Am J Respir Cell Mol Biol 2009, 40(6):654-662. Epub 2008/11/08.
66. He Z., Zhu Y., Jiang H. Toll-like receptor 4 mediates lipopolysaccharide-induced collagen secretion by phosphoinositide3-kinase-Akt pathway in fibroblasts during acute lung injury. JRecept Signal Transduct Res 2009, 29(2):119-125. Epub 2009/06/13.
67. Meneghin A., Choi E.S., Evanoff H.L., Kunkel S.L., Martinez F.J., Flaherty K.R., et al. TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes invitro myofibroblast differentiation. Histochem Cell Biol 2008, 130(5):979-992. Epub 2008/07/18.
68. Sukkar M.B., Xie S., Khorasani N.M., Kon O.M., Stanbridge R., Issa R., et al. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. JAllergy Clin Immunol 2006, 118(3):641-648. Epub 2006/09/05.
69. Manetsch M., Seidel P., Heintz U., Che W., Hughes J.M., Ge Q., et al. TLR2 ligand engagement upregulates airway smooth muscle TNFalpha-induced cytokine production. Am J Physiol Lung Cell Mol Physiol 2012, 302(9):L838-L845. Epub 2012/01/17.
70. Swisher J.F., Burton N., Bacot S.M., Vogel S.N., Feldman G.M. Annexin A2 tetramer activates human and murine macrophages through TLR4. Blood 2010, 115(3):549-558. Epub 2009/12/08.
71. O'Dwyer D.N., Armstrong M.E., Trujillo G., Cooke G., Keane M.P., Fallon P.G., et al. The toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2013, 188(12):1442-1450.
72. He Z., Gao Y., Deng Y., Li W., Chen Y., Xing S., et al. Lipopolysaccharide induces lung fibroblast proliferation through toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway. PLoS One 2012, 7(4):e35926. Epub 2012/05/09.
73. Syrovets T., Lunov O., Simmet T. Plasmin as a proinflammatory cell activator. JLeukoc Biol 2012, 92(3):509-519. Epub 2012/05/09.
74. Schuliga M., Westall G., Xia Y., Stewart A.G. The plasminogen activation system: new targets in lung inflammation and remodeling. Curr Opin Pharmacol 2013, 13(3):386-393. Epub 2013/06/06.
75. Pendurthi U.R., Ngyuen M., Andrade-Gordon P., Petersen L.C., Rao L.V. Plasmin induces Cyr61 gene expression in fibroblasts via protease-activated receptor-1 and p44/42 mitogen-activated protein kinase-dependent signaling pathway. Arterioscler Thromb Vasc Biol 2002, 22(9):1421-1426. Epub 2002/09/17.
76. Schuliga M., Harris T., Stewart A.G. Plasminogen activation by airway smooth muscle is regulated by type I collagen. Am J Respir Cell Mol Biol 2011, 44(6):831-839. Epub 2010/08/10.
77. Schuliga M., Langenbach S., Xia Y.C., Qin C., Mok J.S., Harris T., et al. Plasminogen-stimulated inflammatory cytokine production by airway smooth muscle cells is regulated by annexin A2. Am J Respir Cell Mol Biol 2013, 49(5):751-758. Epub 2013/06/01.
78. Bauman K.A., Wettlaufer S.H., Okunishi K., Vannella K.M., Stoolman J.S., Huang S.K., et al. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. JClin Invest 2010, 120(6):1950-1960. Epub 2010/05/27.
79. Li Q., Laumonnier Y., Syrovets T., Simmet T. Plasmin triggers cytokine induction in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 2007, 27(6):1383-1389. Epub 2007/04/07.
80. Henneke I., Greschus S., Savai R., Korfei M., Markart P., Mahavadi P., et al. Inhibition of urokinase activity reduces primary tumor growth and metastasis formation in a murine lung carcinoma model. Am J Respir Crit Care Med 2010, 181(6):611-619. Epub 2010/01/09.
81. Schmitt M., Harbeck N., Brunner N., Janicke F., Meisner C., Muhlenweg B., et al. Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. Expert Rev Mol Diagn 2011, 11(6):617-634. Epub 2011/07/13.
82. Sharma M., Blackman M.R., Sharma M.C. Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model. Exp Mol Pathol 2012, 92(1):175-184. Epub 2011/11/03.
83. Sharma M., Ownbey R.T., Sharma M.C. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation. Exp Mol Pathol 2010, 88(2):278-286. Epub 2010/01/19.
84. Zheng L., Foley K., Huang L., Leubner A., Mo G., Olino K., et al. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One 2011, 6(4):e19390. Epub 2011/05/17.
85. Chambers R.C., Scotton C.J. Coagulation cascade proteinases in lung injury and fibrosis. Proc Am Thorac Soc 2012, 9(3):96-101. Epub 2012/07/18.
86. Lambrecht B.N., Hammad H. Asthma and coagulation. NEngl J Med 2013, 369(20):1964-1966. Epub 2013/11/15.
87. Tchougounova E., Pejler G. Regulation of extravascular coagulation and fibrinolysis by heparin-dependent mast cell chymase. FASEB J 2001, 15(14):2763-2765. Epub 2001/11/01.
88. Knight D.A., Lim S., Scaffidi A.K., Roche N., Chung K.F., Stewart G.A., et al. Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. JAllergy Clin Immunol 2001, 108(5):797-803. Epub 2001/11/03.
89. Scotton C.J., Krupiczojc M.A., Konigshoff M., Mercer P.F., Lee Y.C., Kaminski N., et al. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. JClin Invest 2009, 119(9):2550-2563. Epub 2009/08/05.
90. Ortiz-Stern A., Deng X., Smoktunowicz N., Mercer P.F., Chambers R.C. PAR-1-dependent and PAR-independent pro-inflammatory signaling in human lung fibroblasts exposed to thrombin. JCell Physiol 2012, 227(11):3575-3584. Epub 2012/01/27.
91. Tran T., Stewart A.G. Protease-activated receptor (PAR)-independent growth and pro-inflammatory actions of thrombin on human cultured airway smooth muscle. Br J Pharmacol 2003, 138(5):865-875. Epub 2003/03/19.
92. Shinagawa K., Martin J.A., Ploplis V.A., Castellino F.J. Coagulation factor Xa modulates airway remodeling in a murine model of asthma. Am J Respir Crit Care Med 2007, 175(2):136-143. Epub 2006/11/04.
93. Zhu W., Bi M., Liu Y., Wang Y., Pan F., Qiu L., et al. Thrombin promotes airway remodeling via protease-activated receptor-1 and transforming growth factor-beta1 in ovalbumin-allergic rats. Inhal Toxicol 2013, 25(10):577-586. Epub 2013/08/14.
94. Bosquet J., Jeffery P.K., Busse W.W., Johnson M., Vigona A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000, 161(5):1720-1745.
95. Pilette C., Francis J.N., Till S.J., Durham S.R. CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge. Eur Respir J 2004, 23(6):876-884. Epub 2004/06/29.
96. Ordonez C.L., Shaughnessy T.E., Matthay M.A., Fahy J.V. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance. Am J Respir Crit Care Med 2000, 161(4 Pt 1):1185-1190. Epub 2000/04/14.
97. Taha R.A., Minshall E.M., Miotto D., Shimbara A., Luster A., Hogg J.C., et al. Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. JAllergy Clin Immunol 1999, 103(3 Pt 1):476-483. Epub 1999/03/09.
98. John Alison E., Zhu Yong M., Brightling Christopher E., Pang Linhua, Knox Alan J. Human airway smooth muscle cells from asthmatic individuals have CXCL8 hypersecretion due to increased NF-{kappa}B p65, C/EBP{beta}, and RNA polymerase II binding to the CXCL8 promoter. JImmunol 2009, 183(7):4682-4692.
99. Chan V., Burgess J.K., Ratoff J.C., O'Connor B.J., Greenough A., Lee T.H., et al. Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med 2006, 174(4):379-385. Epub 2006/05/20.
100. Faiz A., Black J., Oliver B.G., Burgess J. CCL20 production by airway smooth muscle cells contributes to mucus hypersecretion and increased muscle mass in asthmatic airways. Respirology 2013, 18(2):38-85.
101. Araujo B.B., Dolhnikoff M., Silva L.F.F., Elliot J., Lindeman J.H.N., Ferreira D.S., et al. Extracellular matrix components and regulators in the airway smooth muscle in asthma. Eur Respir J 2008, 32(1):61-69.
102. Johnson P.R.A., Burgess J.K., Underwood P.A., Au W., Poniris M.H., Tamm M., et al. Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism. JAllergy Clin Immunol 2004, 113(4):690-696.
103. Lau J.Y., Oliver B.G., Baraket M., Beckett E.L., Hansbro N.G., Moir L.M., et al. Fibulin-1 is increased in asthma - a novel mediator of airway remodeling?. PLoS One 2010, 5(10):e13360. Epub 2010/10/23.
104. Mahn K., Hirst S.J., Ying S., Holt M.R., Lavender P., Ojo O.O., et al. Diminished sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma. Proc Natl Acad Sci U S A 2009, 106(26):10775-10780. Epub 2009/06/23.
105. Trian T., Benard G., Begueret H., Rossignol R., Girodet P.-O., Ghosh D., et al. Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma. JExp Med 2007, 204(13):3173-3181.
106. Alrashdan Y.A., Alkhouri H., Chen E., Lalor D.J., Poniris M., Henness S., et al. Asthmatic airway smooth muscle CXCL10 production: mitogen-activated protein kinase JNK involvement. Am J Physiol Lung Cell Mol Physiol 2012, 302(10):L1118-L1127. Epub 2012/03/06.
107. Tan X., Alrashdan Y.A., Alkhouri H., Oliver B.G., Armour C.L., Hughes J.M. Airway smooth muscle CXCR3 ligand production: regulation by JAK-STAT1 and intracellular Ca(2)(+). Am J Physiol Lung Cell Mol Physiol 2013, 304(11):L790-L802. Epub 2013/04/09.
108. Chang P.J., Bhavsar P.K., Michaeloudes C., Khorasani N., Chung K.F. Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma. JAllergy Clin Immunol 2012, 130(4):877-885.e5. Epub 2012/09/06.
109. Roth M., Johnson P.R.A., Borger P., Bihl M.P., Rudiger J.J., King G.G., et al. Dysfunctional interaction of C/EBP{alpha} and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. NEngl J Med 2004, 351(6):560-574.
110. Hew M., Bhavsar P., Torrego A., Meah S., Khorasani N., Barnes P.J., et al. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006, 174(2):134-141. Epub 2006/04/15.
111. Ingram J.L., Huggins M.J., Church T.D., Li Y., Francisco D.C., Degan S., et al. Airway fibroblasts in asthma manifest an invasive phenotype. Am J Respir Crit Care Med 2011, 183(12):1625-1632. Epub 2011/04/08.
112. Zheng T., Liu W., Oh S.Y., Zhu Z., Hu B., Homer R.J., et al. IL-13 receptor alpha2 selectively inhibits IL-13-induced responses in the murine lung. JImmunol 2008, 180(1):522-529. Epub 2007/12/22.
113. Han M.K., Criner G.J. Update in chronic obstructive pulmonary disease 2012. Am J Respir Crit Care Med 2013, 188(1):29-34. Epub 2013/07/03.
114. Qiu W., Baccarelli A., Carey V.J., Boutaoui N., Bacherman H., Klanderman B., et al. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med 2012, 185(4):373-381. Epub 2011/12/14.
115. Sze M.A., Dimitriu P.A., Hayashi S., Elliott W.M., McDonough J.E., Gosselink J.V., et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012, 185(10):1073-1080. Epub 2012/03/20.
116. Jeffery P.K. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004, 1(3):176-183. Epub 2005/08/23.
117. Hallgren O., Rolandsson S., Andersson-Sjoland A., Nihlberg K., Wieslander E., Kvist-Reimer M., et al. Enhanced ROCK1 dependent contractility in fibroblast from chronic obstructive pulmonary disease patients. JTransl Med 2012, 10:171. Epub 2012/08/24.
118. Hallgren O., Nihlberg K., Dahlback M., Bjermer L., Eriksson L.T., Erjefalt J.S., et al. Altered fibroblast proteoglycan production in COPD. Respir Res 2010, 11:55. Epub 2010/05/13.
119. Zhang J., Wu L., Qu J.M., Bai C.X., Merrilees M.J., Black P.N. Pro-inflammatory phenotype of COPD fibroblasts not compatible with repair in COPD lung. JCell Mol Med 2012, 16(7):1522-1532. Epub 2011/11/29.
120. Larsson-Callerfelt A.K., Hallgren O., Andersson-Sjoland A., Thiman L., Bjorklund J., Kron J., et al. Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts. Respir Res 2013, 14:21. Epub 2013/02/15.
121. Stitham J., Midgett C., Martin K.A., Hwa J. Prostacyclin: an inflammatory paradox. Front Pharmacol 2011, 2:24. Epub 2011/06/21.
122. Nagai S., Handa T., Ito Y., Takeuchi M., Izumi T. Bronchoalveolar lavage in idiopathic interstitial lung diseases. Semin Respir Crit Care Med 2007, 28(5):496-503. Epub 2007/11/03.
123. Nathan N., Thouvenin G., Fauroux B., Corvol H., Clement A. Interstitial lung disease: physiopathology in the context of lung growth. Paediatr Respir Rev 2011, 12(4):216-222. Epub 2011/10/25.
124. Coffey E., Newman D.R., Sannes P.L. Expression of fibroblast growth factor 9 in normal human lung and idiopathic pulmonary fibrosis. JHistochem Cytochem 2013, 61(9):671-679. Epub 2013/06/26.
125. Lindahl G.E., Stock C.J., Shi-Wen X., Leoni P., Sestini P., Howat S.L., et al. Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease. Respir Res 2013, 14:80. Epub 2013/08/07.
126. Nagahama K.Y., Togo S., Holz O., Magnussen H., Liu X., Seyama K., et al. Oncostatin M modulates fibroblast function via signal transducers and activators of transcription proteins-3. Am J Respir Cell Mol Biol 2013, 49(4):582-591. Epub 2013/05/15.
127. Suda T., Chida K., Todate A., Ide K., Asada K., Nakamura Y., et al. Oncostatin M production by human dendritic cells in response to bacterial products. Cytokines 2002, 17(6):335-340. Epub 2002/06/14.
128. Botelho F.M., Rangel-Moreno J., Fritz D., Randall T.D., Xing Z., Richards C.D. Pulmonary expression of oncostatin M (OSM) promotes inducible BALT formation independently of IL-6, despite a role for IL-6 in OSM-driven pulmonary inflammation. JImmunol 2013, 191(3):1453-1464. Epub 2013/06/26.
129. Fritz D.K., Kerr C., Fattouh R., Llop-Guevara A., Khan W.I., Jordana M., et al. Amouse model of airway disease: oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness are STAT6 dependent, and interstitial pulmonary fibrosis is STAT6 independent. JImmunol 2011, 186(2):1107-1118. Epub 2010/12/17.
130. Mozaffarian A., Brewer A.W., Trueblood E.S., Luzina I.G., Todd N.W., Atamas S.P., et al. Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis. JImmunol 2008, 181(10):7243-7253. Epub 2008/11/05.
131. Smyth D.C., Kerr C., Li Y., Tang D., Richards C.D. Oncostatin M induction of eotaxin-1 expression requires the convergence of PI3'K and ERK1/2 MAPK signal transduction pathways. Cell Signal 2008, 20(6):1142-1150. Epub 2008/03/29.
132. Pak O., Aldashev A., Welsh D., Peacock A. The effects of hypoxia on the cells of the pulmonary vasculature. Eur Respir J 2007, 30(2):364-372. Epub 2007/08/02.
133. Crosswhite P., Sun Z. Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension. JHypertens 2010, 28(2):201-212. Epub 2010/01/07.
134. Stenmark K.R., Frid M.G., Yeager M., Li M., Riddle S., McKinsey T., et al. Targeting the adventitial microenvironment in pulmonary hypertension: a potential approach to therapy that considers epigenetic change. Pulm Circ 2012, 2(1):3-14. Epub 2012/05/05.
135. Wang D., Zhang H., Li M., Frid M.G., Flockton A.R., McKeon B.A., et al. MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts. Circ Res 2014, 114(1):67-78.
136. Schabbauer G., Matt U., Gunzl P., Warszawska J., Furtner T., Hainzl E., et al. Myeloid PTEN promotes inflammation but impairs bactericidal activities during murine pneumococcal pneumonia. JImmunol 2010, 185(1):468-476. Epub 2010/05/28.
137. Horita H., Furgeson S.B., Ostriker A., Olszewski K.A., Sullivan T., Villegas L.R., et al. Selective inactivation of PTEN in smooth muscle cells synergizes with hypoxia to induce severe pulmonary hypertension. JAm Heart Assoc 2013, 2(3):e000188. Epub 2013/06/04.
138. Brightling C.E., Bradding P., Symon F.A., Holgate S.T., Wardlaw A.J., Pavord I.D. Mast-cell infiltration of airway smooth muscle in asthma. NEngl J Med 2002, 346(22):1699-1705.
139. Amin K., Janson C., Harvima I., Venge P., Nilsson G. CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma. JAllergy Clin Immunol 2005, 116(6):1383-1386. Epub 2005/12/13.
140. Begueret H., Berger P., Vernejoux J.M., Dubuisson L., Marthan R., Tunon-de-Lara J.M. Inflammation of bronchial smooth muscle in allergic asthma. Thorax 2007, 62(1):8-15.
141. Carroll N.G., Mutavdzic S., James A.L. Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax 2002, 57(8):677-682. Epub 2002/08/01.
142. Sutcliffe A., Kaur D., Page S., Woodman L., Armour C.L., Baraket M., et al. Mast cell migration to Th2 stimulated airway smooth muscle from asthmatics. Thorax 2006, 61(8):657-662.
143. Juremalm M., Hjertson M., Olsson N., Harvima I., Nilsson K., Nilsson G. The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin. Eur J Immunol 2000, 30(12):3614-3622. Epub 2001/02/13.
144. Juremalm M., Olsson N., Nilsson G. Selective CCL5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. Biochem Biophys Res Commun 2002, 297(3):480-485. Epub 2002/09/25.
145. Berger P., Girodet P.O., Begueret H., Ousova O., Perng D.W., Marthan R., et al. Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis. FASEB J 2003, 17(14):2139-2141. Epub 2003/09/23.
146. Alkhouri H., Hollins F., Moir L.M., Brightling C.E., Armour C.L., Hughes J.M. Human lung mast cells modulate the functions of airway smooth muscle cells in asthma. Allergy 2011, 66(9):1231-1241. Epub 2011/05/12.
147. Hollins F., Kaur D., Yang W., Cruse G., Saunders R., Sutcliffe A., et al. Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: cooperative roles for CADM1, stem cell factor, and IL-6. JImmunol 2008, 181(4):2772-2780. Epub 2008/08/08.
148. Bradding P. Mast cell regulation of airway smooth muscle function in asthma. Eur Respir J 2007, 29(5):827-830.
149. John A.E., Lukacs N.W. Chemokines and asthma. Sarcoidosis Vasc Diffuse Lung Dis 2003, 20(3):180-189. Epub 2003/11/19.
150. Page S., Ammit A.J., Black J.L., Armour C.L. Human mast cell and airway smooth muscle cell interactions: implications for asthma. Am J Physiol Lung Cell Mol Physiol 2001, 281(6):L1313-L1323. Epub 2001/11/13.
151. Kitamura H., Cambier S., Somanath S., Barker T., Minagawa S., Markovics J., et al. Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin alphavbeta8-mediated activation of TGF-beta. JClin Invest 2011, 121(7):2863-2875. Epub 2011/06/08.
152. Pechkovsky D.V., Prasse A., Kollert F., Engel K.M., Dentler J., Luttmann W., et al. Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin Immunol 2010, 137(1):89-101. Epub 2010/08/03.
153. Kunz L.I., Lapperre T.S., Snoeck-Stroband J.B., Budulac S.E., Timens W., van Wijngaarden S., et al. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD. Respir Res 2011, 12:34. Epub 2011/03/24.
154. Prasse A., Pechkovsky D.V., Toews G.B., Jungraithmayr W., Kollert F., Goldmann T., et al. Avicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med 2006, 173(7):781-792. Epub 2006/01/18.
155. Barnes P.J. New anti-inflammatory targets for chronic obstructive pulmonary disease. Nat Rev Drug Discov 2013, 12(7):543-559. Epub 2013/08/27.
156. Tannheimer S.L., Wright C.D., Salmon M. Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts. Respir Res 2012, 13:28. Epub 2012/03/29.
157. Michalski J., Kanaji N., Liu X., Nogel S., Wang X., Basma H., et al. Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4. Am J Respir Cell Mol Biol 2012, 47(6):729-737. Epub 2012/10/09.
158. Sato T., Liu X., Nelson A., Nakanishi M., Kanaji N., Wang X., et al. Reduced miR-146a increases prostaglandin E(2)in chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med 2010, 182(8):1020-1029. Epub 2010/06/05.
159. Togo S., Holz O., Liu X., Sugiura H., Kamio K., Wang X., et al. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med 2008, 178(3):248-260. Epub 2008/05/10.
160. Okunishi K., Sisson T.H., Huang S.K., Hogaboam C.M., Simon R.H., Peters-Golden M. Plasmin overcomes resistance to prostaglandin E2 in fibrotic lung fibroblasts by reorganizing protein kinase A signaling. JBiol Chem 2011, 286(37):32231-32243. Epub 2011/07/29.
161. Xie S., Sukkar M.B., Issa R., Oltmanns U., Nicholson A.G., Chung K.F. Regulation of TGF-beta 1-induced connective tissue growth factor expression in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2005, 288(1):L68-L76. Epub 2004/09/21.
162. Wynn T.A. Integrating mechanisms of pulmonary fibrosis. JExp Med 2011, 208(7):1339-1350. Epub 2011/07/06.
163. Yndestad A., Larsen K.O., Oie E., Ueland T., Smith C., Halvorsen B., et al. Elevated levels of activin A in clinical and experimental pulmonary hypertension. JAppl Physiol (1985) 2009, 106(4):1356-1364. Epub 2009/02/07.
164. Aoki F., Kurabayashi M., Hasegawa Y., Kojima I. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Am J Respir Crit Care Med 2005, 172(6):713-720. Epub 2005/06/25.
165. Ponticos M., Holmes A.M., Shi-wen X., Leoni P., Khan K., Rajkumar V.S., et al. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Arthritis Rheum 2009, 60(7):2142-2155. Epub 2009/07/01.
166. Lu J., Auduong L., White E.S., Yue X. Upregulation of heparan sulfate 6-O-Sulfation in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2014, 50(1):106-114.
167. Gallelli L., Falcone D., Pelaia G., Renda T., Terracciano R., Malara N., et al. Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts. Cell Prolif 2008, 41(3):393-407. Epub 2008/04/26.
168. Baarsma H.A., Engelbertink L.H., van Hees L.J., Menzen M.H., Meurs H., Timens W., et al. Glycogen synthase kinase-3 (GSK-3) regulates TGF-beta(1)-induced differentiation of pulmonary fibroblasts. Br J Pharmacol 2013, 169(3):590-603. Epub 2013/01/10.
169. Baarsma H.A., Meurs H., Halayko A.J., Menzen M.H., Schmidt M., Kerstjens H.A., et al. Glycogen synthase kinase-3 regulates cigarette smoke extract- and IL-1beta-induced cytokine secretion by airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2011, 300(6):L910-L919. Epub 2011/03/23.
170. Manetsch M., Rahman M.M., Patel B.S., Ramsay E.E., Rumzhum N.N., Alkhouri H., et al. Long-acting beta2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells. PLoS One 2013, 8(3):e59635. Epub 2013/03/28.
171. Quante T., Ng Y.C., Ramsay E.E., Henness S., Allen J.C., Parmentier J., et al. Corticosteroids reduce IL-6 in ASM cells via up-regulation of MKP-1. Am J Respir Cell Mol Biol 2008, 39(2):208-217. Epub 2008/03/04.
172. Che W., Manetsch M., Quante T., Rahman M.M., Patel B.S., Ge Q., et al. Sphingosine 1-phosphate induces MKP-1 expression via p38 MAPK- and CREB-mediated pathways in airway smooth muscle cells. Biochim Biophys Acta 2012, 1823(10):1658-1665. Epub 2012/06/30.
173. Manetsch M., Che W., Seidel P., Chen Y., Ammit A.J. MKP-1: a negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells. Cell Signal 2012, 24(4):907-913. Epub 2011/12/28.
174. Doddareddy M.R., Rawling T., Ammit A.J. Targeting mitogen-activated protein kinase phosphatase-1 (MKP-1): structure-based design of MKP-1 inhibitors and upregulators. Curr Med Chem 2012, 19(2):163-173. Epub 2012/02/11.
175. Abraham E., Gyetko M.R., Kuhn K., Arcaroli J., Strassheim D., Park J.S., et al. Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation. JImmunol 2003, 170(11):5644-5651. Epub 2003/05/22.
176. Swaisgood C.M., French E.L., Noga C., Simon R.H., Ploplis V.A. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol 2000, 157(1):177-187. Epub 2000/07/06.
177. Wang X.Q., Bdeir K., Yarovoi S.V., Cines D.B., Fang W., Abraham E. Involvement of the urokinase kringle domain in lipopolysaccharide-induced acute lung injury. JImmunol 2006, 177(8):5550-5557.